Thursday, May 17, 2012

Stem-Cell-Based Drug Approved in Canada for Treatment of Graft-Versus-Host Disease

Stem cellThe New York Times: A Stem-Cell-Based Drug Gets Approval in Canada, by Andrew Pollack:

In a boost for the field of regenerative medicine, a small biotechnology company has received regulatory approval in Canada for what it says is the first manufactured drug based on stem cells.

The company, Osiris Therapeutics of Columbia, Md., said Thursday that Canadian regulators had approved its drug Prochymal, to treat children suffering from graft-versus-host disease, a potentially deadly complication of bone marrow transplantation. . . .

https://lawprofessors.typepad.com/reproductive_rights/2012/05/canada-approves-stem-cell-based-drug-for-treatment-of-graft-versus-host-disease.html

Bioethics, International, Medical News, Stem Cell Research | Permalink

TrackBack URL for this entry:

https://www.typepad.com/services/trackback/6a00d8341bfae553ef016766938496970b

Listed below are links to weblogs that reference Stem-Cell-Based Drug Approved in Canada for Treatment of Graft-Versus-Host Disease:

Comments

Post a comment